Health Data Analytics Institute (HDAI) is a Boston-based AI company focused on empowering clinicians, optimizing care pathways, and improving patient outcomes. Its core product, HealthVision, is a predictive risk platform that uses predictive analytics and generative AI to analyze a patient’s medical history, including unstructured clinical notes and administrative data. HealthVision creates concise summaries of a patient’s clinical chart, state of health, and quantifies and prioritizes specific clinical risks. HDAI positions itself as a care optimization, decision support, and provider enablement company powered by big data, AI-powered analytics, expert insights, and point-of-care technology solutions. The company collaborates with health systems, value-based care organizations, physician groups, and payers to improve care delivery, population health, and reduce costs. Several health systems including Houston Methodist, Cleveland Clinic, and Dana-Farber Cancer Institute are collaborating with HDAI on various initiatives. HDAI received $31M in Series C financing and intends to use the funds to scale its predictive risk platform. Health Data Analytics Institute (HDAI) develops an AI-powered platform that analyzes over a billion patient encounters to predict clinical and financial outcomes. Its model was trained on data from over 100 million people in the U.S. with more than 20 years of follow-up and offers predictors for in-hospital complications, mortality risk, total cost of care, and risks of developing chronic conditions. HDAI says its predictors can be applied to both paper charts and electronic health records, generalize across geographies and populations, and update as individuals and populations age. The company works with health systems — including New England Baptist Hospital, Cleveland Clinic, and Houston Methodist — and with carriers and pharmaceutical clients on pilots and studies. HDAI plans to launch an API to widen access to its clinical prediction service and will use the recent funding to support that effort. The company has roots in academic studies dating back to 2002, is based in Dedham, Massachusetts, has about 25 employees, and is led by founder and CEO Nassib Chamoun.

Total raised

$47M

Funding rounds

2

Latest round

Series C

Latest activity

Oct 2023